To analyze the anti-AML activity of the TRAIL-coated oncolytic adenoviruses in vivo, subcutaneous tumor-bearing BALB/c nude mouse models were treated with three different types of oncolytic adenovirus vectors (Fig. 5c). This evidence concerns the gene TNFSF10 and acute myeloid leukemia.